Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-γ:: effect of dose and formulation

被引:14
作者
Griffin, KF
Conway, BR [1 ]
Alpar, HO
Williamson, ED
机构
[1] CBD Porton Down, Salisbury SP4 0JQ, Wilts, England
[2] Aston Univ, Dept Pharmaceut & Biol Sci, Birmingham B4 7ET, W Midlands, England
关键词
Yersinia pestis; V antigen; poly(L)lactide microspheres; interferon-gamma;
D O I
10.1016/S0264-410X(97)80005-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Induction of systemic immune responses after intraperitoneal inoculation of poly(L)lactide microspheres containing the V antigen of Yersinia pestis co-encapsulated with IFN-gamma were investigated. Serum antibody responses and T cell proliferative responses were measured in groups of Balb/c mice which were injected intraperitoneally with single or double emulsion preparations of either V/IFN-gamma or V alone in a range of dose levels. Groups which received V antigen co-encapsulated with IFN-gamma produced higher V-specific antibody responses, predominantly of the IgG1 isotype. Administration of 25 mu g V/IFN-gamma in a single emulsion resulted in a significantly increased (p<0.05) splenic T cell proliferative response to V antigen compared with other formulations. Ii was concluded that IFN-gamma co-encapsulated with V antigen in poly(L)lactide microspheres acted as an adjuvant and increased antigen specific systemic immune responses. Therefore, cc-encapsulation with IFN-gamma may result in effective single nose vaccines by increasing the immunogenicity of the formulations. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 18 条
[1]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[2]   Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis [J].
Anderson, GW ;
Leary, SEC ;
Williamson, ED ;
Titball, RW ;
Welkos, SL ;
Worsham, PL ;
Friedlander, AM .
INFECTION AND IMMUNITY, 1996, 64 (11) :4580-4585
[3]  
BECK LR, 1979, FERTIL STERIL, V31, P545
[4]  
Conway BR, 1996, EUR J PHARM BIOPHARM, V42, P42
[5]  
CONWAY BR, 1996, PHARM SCI, V2, P173
[6]   CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].
ELDRIDGE, JH ;
HAMMOND, CJ ;
MEULBROEK, JA ;
STAAS, JK ;
GILLEY, RM ;
TICE, TR .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214
[7]  
GRAY PW, 1994, GUIDEBOOK CYTOKINES
[8]  
HEATH AW, 1990, IMMUNOLOGY, V71, P454
[9]   ACTIVE IMMUNIZATION WITH RECOMBINANT V-ANTIGEN FROM YERSINIA-PESTIS PROTECTS MICE AGAINST PLAGUE [J].
LEARY, SEC ;
WILLIAMSON, ED ;
GRIFFIN, KF ;
RUSSELL, P ;
ELEY, SM ;
TITBALL, RW .
INFECTION AND IMMUNITY, 1995, 63 (08) :2854-2858
[10]  
MEYER KF, 1970, B WORLD HEALTH ORGAN, V42, P653